Irish Examiner on MSN
Ozempic, Wegovy and Mounjaro: Why Ireland is struggling to fund the new weight-loss drugs
New weight-loss drugs promise transformative benefits, but soaring demand and massive cost projections leave Ireland facing difficult funding choices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback